PFE—Prevnar-20 results in EU infants looks good enough for EU approval: https://finance.yahoo.com/news/pfizer-announces-positive-top-line-104500704.html The main difference between these data and the data from PFE’s similar phase-3 trial in the US (#msg-169661718) is the number of shots in the treatment course: 3 in the EU; 4 in the US. Please see #msg-169661718 for related info.